欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/H/0251/001
药品名称INFANRIXTETRA
活性成分
    • A/Fujian/411/2002 (H3N2) - like virus aceponate 0.0 cm2
剂型Powder and solvent for suspension for injection
上市许可持有人Glaxosmithkline
参考成员国 - 产品名称France (FR)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Denmark (DK)
    • Ireland (IE)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
      Infanrix Polio
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Infanrix-IPV
    • Latvia (LV)
    • Lithuania (LT)
      Infanrix Polio injekcinė suspensija
    • Estonia (EE)
      INFANRIX POLIO
    • Hungary (HU)
      Infanrix Polio szuszp. inj. előretöltött fecskendőben
    • Cyprus (CY)
      INFANRIX TETRA SUSPENSION FOR INJECTION
    • Czechia (CZ)
      1491/06
    • Slovakia (SK)
      Infanrix Polio
许可日期2004/05/21
最近更新日期2022/12/27
药物ATC编码
    • J07CA02 diphtheria-pertussis-poliomyelitis-tetanus
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Biological: Vaccine
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase